Ann: Aroa Biosurgery Half Yearly Results H1 FY23, page-8

First 8 Last

Share
Profile

Follow
win8

359 Posts.

31

29/11/22

14:42

Post #: 65050468
Share

Originally posted by squaremile: ↑

Hi there Win8 and other LTH's,

Did anyone go to the webinar today? Unfortunately, I arrived late and missed most of the presentation. Although, just enough time to ask Brian Ward a question. "Looking to the future, and given the size of Aroa's addressable market(s) - in terms of revenue how big do you think Aroa could get in the next 5 to 10 years" - I know the question is meaningless as who could have forecast what has happened over the past 3 years. But I thought I would ask anyway to see what Brian's response would be.
Brian said he was confident that revenue would be over $100m within the next 2 years and beyond that revenue would likely to grow at 30% to 40% p.a. If Aroa can obtain this level of revenue and can maintain its gross margin of 84% and get its operational expenses under control, Aroa has an exciting profitable future ahead, which I am happy to be part of.
Cheers

Expand

I heard ur question. I listened to the entire session.
nothing to worry about and great prospects, as expected.

Brian also stressed that the company's current market share is still so small compare to its total addressable market. current sales cost recovery period is 12 months but they start to see it will be shorten to 6 months

Symphony won't require additional salespersons. the company is going to ultilise the synergies from its sales team (eg cross-selling).

Last edited by win8: 29/11/22
3 Upvote

0 Great analysis

Reply